Form 8-K - Current report:
SEC Accession No. 0001171843-21-001119
Filing Date
2021-02-18
Accepted
2021-02-18 07:30:12
Documents
12
Period of Report
2021-02-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_021821.htm   iXBRL 8-K 22528
  Complete submission text file 0001171843-21-001119.txt   193179

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cytk-20210217.xsd EX-101.SCH 2772
3 XBRL LABEL FILE cytk-20210217_lab.xml EX-101.LAB 34592
4 XBRL PRESENTATION FILE cytk-20210217_pre.xml EX-101.PRE 22721
5 EXTRACTED XBRL INSTANCE DOCUMENT f8k_021821_htm.xml XML 3501
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 21647671
SIC: 2834 Pharmaceutical Preparations